BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 17, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Apaziquone: Phase I started

Nippon Kayaku began a Japanese Phase I trial to evaluate an immediate dose of apaziquone in up to 6 patients following transurethral resection of bladder tumor, followed by 6 weekly doses of apaziquone starting at week...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >